06063768 is referenced by 160 patents and cites 7 patents.

The present invention provides a method for the use of at least one serotype or a combination of serotypes of Botulinum neurotoxin either alone or in combination with other peptides or fusion proteins, that when administered in a safe and effective amount, antagonize and therefore decrease or block inflammation induced by the neurogenic mechanisms underlying or associated with inflammatory disorders, in particular, arthritis.

Title
Application of botulinum toxin to the management of neurogenic inflammatory disorders
Application Number
8/923884
Publication Number
6063768
Application Date
September 4, 1997
Publication Date
May 16, 2000
Inventor
Eric R First
52-N-St., South Boston, 02127
MA, US
Agent
Thomas J Nutter McClennen & Fish Engellenner
IPC
A61K 45/05
A61K 45/00
A61K 38/00
View Original Source